Neoadjuvant Study of Camrelizumab Plus Chemotherapy in Triple Negative Breast Cancer (TNBC)
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Triple Negative Breast Cancer
Related studies linked through entity extraction aliases.
Comparison of TP and TAC Regimens in Neoadjuvant Treatment of TNBC
- Status
- COMPLETED
- Phase
- PHASE2
ARGONAUT: Stool and Blood Sample Bank for Cancer Patients
- Status
- RECRUITING
- Phase
- N/A
A Study of Camrelizumab Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC)
- Status
- COMPLETED
- Phase
- PHASE3
ImmunoBreast - A Phase Ib Study
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Sacituzumab Govitecan in Primary HER2-negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
INCB106385 Alone or in Combination With Immunotherapy in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Fruquintinib in Combination With Tislelizumab in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Multicenter Cancer Biospecimen Collection Study
- Status
- RECRUITING
- Phase
- N/A
Maintenance Treatment With Eribulin Mesylate Versus Observation in Triple Negative Breast Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Palbociclib and Binimetinib in Advanced Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
- Status
- RECRUITING
- Phase
- PHASE2
Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Ipatasertib Plus Non-Taxane Chemotherapy for Advanced or Metastatic Triple-Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of AL101 Monotherapy in Patients With Notch Activated Triple Negative Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Oral Etoposide Combined With Anlotinib in Advanced Triple Negative Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Pre-op Pembro + Radiation Therapy in Breast Cancer (P-RAD)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of NM21-1480 in Adult Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2